Photo from www.mvrcancerhospital.com
Sep 3, 2023, 17:24
Anu R I: Published!!! One of our largest studies on MUTYH in cancer.
Anu R I, a precision oncology specialist and a consultant of clinical biochemistry at MVR CCRI, India, recently tweeted:
“Published!!! One of our largest studies on MUTYH in cancer.
2,29,120 patients,
MUTYH alteration is associated with increased TMB, elevated KRAS G12C mutation, higher SBS18 and SBS36 mutations,
Higher neoantigen load,
Potential immunotherapy benefits.”
For the article click here.
Source: Anu R I/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46